Although all of those have shown to be clinically relevant at a certain level [5], phosphorylation, and specifically hyperphosphorylation of the glycine-rich C-terminal domain, has been the most consistent marker of TDP-43 pathology in ALS patient brain and spinal cord [62]. Here, TARDBP is linked to amyotrophic lateral sclerosis.